Navigation Links
Yongye International Announces Conference Call to Discuss Fourth Quarter and Full Year 2010 Results
Date:3/9/2011

BEIJING, March 9, 2011 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (Nasdaq: YONG) ("Yongye" or the "Company"), a leading agricultural nutrient company in China, today announced that the Company will host a conference call at 8:00 a.m. Eastern Time on Tuesday, March 15, 2011, to discuss its fourth quarter and full year 2010 results.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (866) 759-2078. International callers should dial +1 (706) 643-0585. The conference pass code is 50180885.

For those who are unable to participate in the conference call at the time of the call, a replay will be available from 9:00 am Eastern Time on March 15th to 23:59 Eastern Time on March 29th. To access the replay, please dial (800) 642-1687. International callers should dial +1 (706) 645-9291. The replay pass code is 50180885.

About Yongye InternationalYongye International is a leading agricultural nutrient company headquartered in Beijing, with its production facilities located in Hohhot, Inner Mongolia, China. Yongye produces and markets two lines of organic nutrient products: a liquid nutrient product which is sprayed on plants and a powder nutrient product which is added to animal feed. Both products are sold under the brand name "Shengmingsu," which means "life essential" in Chinese. The Company's patented technologies and formulas allow it to create products that increase crop yields and improve the health of livestock. The Company sells its products primarily to provincial or regional level distributors, who then channel those products to a carefully selected network of over 24,000 independently owned, Yongye branded stores or directly to rural farmers and government farms in China. For more information, please visit the Company's website at http://www.yongyeintl.com.Contact:Yongye International

CCG Investor RelationsMs. Kelly Wang

Mr. Athan DounisFinance Director, Capital Markets

Phone: +1-646-213-1916Phone: +86-10-8231-9608

E-mail: athan.dounis@ccgir.comE-mail: ir@yongyeintl.comMs. Wendy Xuan-Business Associate Phone: +86-10-8232-8866 x 8827E-mail: ir@yongyeintl.com
'/>"/>

SOURCE Yongye International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference
2. Yongye International Expands Its Existing Production Capacity by 50% and Provides Updates on Customer List Acquisition
3. Yongye International Hosts Official NASDAQ Visit to Inner Mongolia
4. Yongye International Announces First Quarter 2010 Results
5. Yongye International Announces Conference Call to Discuss First Quarter Fiscal Year 2010 Results
6. Yongye International to Present at Upcoming Investor Conferences
7. Yongye International, Inc. Begins Construction of New Production Facility
8. Yongye International Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Results
9. Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results
10. Yongye International Announces 2010-2012 Strategic Plan
11. Yongye International Announces Expansion of Research and Development Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)...  Perkotek an innovation leader in attendance control systems is proud to announce the ... employers to make sure the right employees are actually signing in, and to even ... ... ... ...
Breaking Biology News(10 mins):